Browse Category

Investment Analysis News 25 December 2025

Nvidia (NVDA) Stock After Hours Today, Dec. 25, 2025: Groq Licensing Deal, CES 2026 Spotlight, and What to Watch Before the Market Opens Dec. 26

Nvidia (NVDA) Stock After Hours Today, Dec. 25, 2025: Groq Licensing Deal, CES 2026 Spotlight, and What to Watch Before the Market Opens Dec. 26

December 25, 2025 — After-hours recap and pre-market preview NVIDIA Corporation (NASDAQ: NVDA) enters the final stretch of 2025 with investors digesting a major strategic headline—a non-exclusive AI inference technology licensing agreement with chip start-up Groq and the departure of
Ondas Holdings (ONDS) Stock: Latest News, Analyst Forecasts, and What’s Driving the Defense-Tech Story (Dec. 25, 2025)

Ondas Holdings (ONDS) Stock: Latest News, Analyst Forecasts, and What’s Driving the Defense-Tech Story (Dec. 25, 2025)

Ondas Holdings Inc. (NASDAQ: ONDS) heads into the Christmas holiday with investors focused less on day-to-day trading (U.S. markets are closed on December 25) and more on a late‑2025 sequence of contracts, acquisitions, and defense-focused expansion moves that have reshaped
Bristol-Myers Squibb (BMY) Stock News, Forecasts and Outlook as of Dec. 25, 2025: Breyanzi FDA Win, Eliquis Medicaid Deal, and 2026 Catalysts

Bristol-Myers Squibb (BMY) Stock News, Forecasts and Outlook as of Dec. 25, 2025: Breyanzi FDA Win, Eliquis Medicaid Deal, and 2026 Catalysts

Bristol-Myers Squibb Company (NYSE: BMY) heads into Dec. 25, 2025 with its stock anchored in the mid-$50s — and with investors juggling two competing storylines: With U.S. markets effectively pausing for the holiday, the most recent available NYSE quote showed
1 43 44 45 46 47 228
Go toTop